The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker
- PMID: 32569788
- DOI: 10.1016/j.micpath.2020.104355
The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker
Abstract
Background: The emerging relationship between microRNAs (miRNA) and viral-control is a topic of interest in the field of HIV. Host-genome might play an important role in the control of viremia. The aim of this study was to assess the specific miRNA profile that could contribute to the control of HIV replication in Elite Controllers.
Materials and methods: The expression level of miRNAs was evaluated in 6 group patients, Elite Controller (EC), HIV, HBV, HCV, HIV-HBV-HIV-HCV, and healthy controls using real-time PCR assays. Also, liver enzymes (ALT and AST) and CD4 T cell count was assessed.
Results: After adequate normalization, expression level of miRNAs was determined. The expression level of miR-146 in HIV/HCV co-infected patients was the highest in all groups. The miRNAs expression profile was significantly different in patient groups compared to control and EC. Some miRNA was significantly correlated with viral load and CD4 T cell count.
Conclusions: The involvement of the mentioned miRNAs and correlation of these with viral and cellular parameters can justify the clinical outcome of all patient groups. The differentially expressed miRNA profile in patients suggests that miRNAs can be serve as biomarkers for risk of disease progression and differentiation of infections. Moreover, determining the profiles of miRNAs due to involvement of these in the pathogenesis of infection and manipulating these miRNAs could lead to opening a new gate to infection control.
Keywords: Elite controller; HBV; HCV; HIV; MicroRNA.
Copyright © 2020. Published by Elsevier Ltd.
Similar articles
-
New Potential MicroRNA Biomarkers in Human Immunodeficiency Virus Elite Controllers, Human Immunodeficiency Virus Infections, and Coinfections with Hepatitis B Virus or Hepatitis C Virus.Intervirology. 2023;66(1):122-135. doi: 10.1159/000533595. Epub 2023 Sep 12. Intervirology. 2023. PMID: 37699384
-
MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients.Curr HIV Res. 2021;19(1):27-34. doi: 10.2174/1570162X18666200908112113. Curr HIV Res. 2021. PMID: 32900348
-
Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors.PLoS One. 2014 Sep 16;9(9):e106360. doi: 10.1371/journal.pone.0106360. eCollection 2014. PLoS One. 2014. PMID: 25225963 Free PMC article.
-
MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy.Viruses. 2012 Oct 26;4(11):2485-513. doi: 10.3390/v4112485. Viruses. 2012. PMID: 23202492 Free PMC article. Review.
-
Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.Trop Gastroenterol. 2008 Jul-Sep;29(3):136-47. Trop Gastroenterol. 2008. PMID: 19115605 Review.
Cited by
-
MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4+ T cells.iScience. 2022 Sep 28;25(10):105234. doi: 10.1016/j.isci.2022.105234. eCollection 2022 Oct 21. iScience. 2022. PMID: 36267915 Free PMC article.
-
Role of miRNA dysregulation in sepsis.Mol Med. 2022 Aug 19;28(1):99. doi: 10.1186/s10020-022-00527-z. Mol Med. 2022. PMID: 35986237 Free PMC article. Review.
-
Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.Int Immunopharmacol. 2021 Aug;97:107641. doi: 10.1016/j.intimp.2021.107641. Epub 2021 Apr 6. Int Immunopharmacol. 2021. PMID: 33895478 Free PMC article.
-
The key role of microRNA-766 in the cancer development.Front Oncol. 2023 May 2;13:1173827. doi: 10.3389/fonc.2023.1173827. eCollection 2023. Front Oncol. 2023. PMID: 37205191 Free PMC article. Review.
-
Comparison and Correlation of Genetic Variability of the HBV Pre-S Region in HIV/HBV Co-Infected Patients: Quasispecies Perspective.Infect Drug Resist. 2020 Dec 1;13:4327-4334. doi: 10.2147/IDR.S278415. eCollection 2020. Infect Drug Resist. 2020. PMID: 33293836 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials